ARCHIVES

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

This article is from The Cancer Letter archive.

Vol. 02 No. 41 | October 8, 1976

Download PDF Visit The Full Archive

Related Articles

Chemotherapy After Surgery Extends Survival By 32%

January 27, 2006

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

In Brief: Eight Site Visits at Prospective Comprehensive Centers Scheduled For NCCAB Members In ’75, 76

July 4, 1975

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

No Issue Next Week

August 22, 1980